249 related articles for article (PubMed ID: 27036951)
1. Identification of Polycomb Group Protein EZH2-Mediated DNA Mismatch Repair Gene MSH2 in Human Uterine Fibroids.
Yang Q; Laknaur A; Elam L; Ismail N; Gavrilova-Jordan L; Lue J; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Oct; 23(10):1314-25. PubMed ID: 27036951
[TBL] [Abstract][Full Text] [Related]
2. The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids.
Yang Q; Nair S; Laknaur A; Ismail N; Diamond MP; Al-Hendy A
Biol Reprod; 2016 Mar; 94(3):69. PubMed ID: 26888970
[TBL] [Abstract][Full Text] [Related]
3. A Preliminary Study: Human Fibroid Stro-1
Prusinski Fernung LE; Al-Hendy A; Yang Q
Reprod Sci; 2019 May; 26(5):619-638. PubMed ID: 29954254
[TBL] [Abstract][Full Text] [Related]
4. EZH2 activates Wnt/β-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate.
Ali M; Stone D; Laknaur A; Yang Q; Al-Hendy A
F S Sci; 2023 Aug; 4(3):239-256. PubMed ID: 37182601
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells.
Prusinski Fernung LE; Yang Q; Sakamuro D; Kumari A; Mas A; Al-Hendy A
Biol Reprod; 2018 Oct; 99(4):735-748. PubMed ID: 29688260
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
7. Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic Regulation.
Yang Q; Diamond MP; Al-Hendy A
Front Pharmacol; 2016; 7():40. PubMed ID: 26973527
[TBL] [Abstract][Full Text] [Related]
8. 4-Nonylphenol-enhanced
Ghosh K; Chatterjee B; Maheswari U; Athifa M; Kanade SR
Epigenomics; 2019 Jun; 11(8):899-916. PubMed ID: 31144530
[No Abstract] [Full Text] [Related]
9. Interference with endogenous EZH2 reverses the chemotherapy drug resistance in cervical cancer cells partly by up-regulating Dicer expression.
Cai L; Wang Z; Liu D
Tumour Biol; 2016 May; 37(5):6359-69. PubMed ID: 26631032
[TBL] [Abstract][Full Text] [Related]
10. H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas.
Cao T; Jiang Y; Wang Z; Zhang N; Al-Hendy A; Mamillapalli R; Kallen AN; Kodaman P; Taylor HS; Li D; Huang Y
Oncogene; 2019 Jul; 38(27):5356-5366. PubMed ID: 31089260
[TBL] [Abstract][Full Text] [Related]
11. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
12. JAK2 regulates mismatch repair protein-mediated epigenetic alterations in response to oxidative damage.
Ding N; Miller SA; Savant SS; O'Hagan HM
Environ Mol Mutagen; 2019 May; 60(4):308-319. PubMed ID: 30548332
[TBL] [Abstract][Full Text] [Related]
13. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic suppression of iNOS expression in human endothelial cells: A potential role of Ezh2-mediated H3K27me3.
Dreger H; Ludwig A; Weller A; Baumann G; Stangl V; Stangl K
Genomics; 2016 Apr; 107(4):145-9. PubMed ID: 26853880
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
Yang Q; Vafaei S; Falahati A; Khosh A; Bariani MV; Omran MM; Bai T; Siblini H; Ali M; He C; Boyer TG; Al-Hendy A
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255982
[TBL] [Abstract][Full Text] [Related]
16. Relative overexpression of the parathyroid hormone-related protein gene in human leiomyomas.
Weir EC; Goad DL; Daifotis AG; Burtis WJ; Dreyer BE; Nowak RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):784-9. PubMed ID: 8126157
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression and regulation of NR2F2 and CTNNB1 in uterine fibroids.
Zaitseva M; Holdsworth-Carson SJ; Waldrip L; Nevzorova J; Martelotto L; Vollenhoven BJ; Rogers PA
Reproduction; 2013 Aug; 146(2):91-102. PubMed ID: 23704310
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC
Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318
[TBL] [Abstract][Full Text] [Related]
20. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia.
Chen J; Li J; Han Q; Sun Z; Wang J; Wang S; Zhao RC
Exp Biol Med (Maywood); 2012 Sep; 237(9):1110-6. PubMed ID: 22956625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
